psoriatic

Latest stories

  • in Health care

    Late-onset Psoriatic Arthritis linked to increased cardiovascular risk

    Late-onset Psoriatic Arthritis linked to increased cardiovascular risk

    by

    Greece: According to a recent study published in Life (Basel) Journal, psoriatic arthritis (PsA) is becoming increasingly common in older people and is associated with an elevated cardiovascular risk. The study aimed to explore whether late-onset PsA patients, diagnosed at 60 years of age or older, displayed different clinical features, treatment approaches, and comorbidity profiles […] More

  • in Health care

    Shilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay

    Shilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay

    by

    Karnataka: Shilpa Medicare has recently announced that the Company has received final approval from the U.S Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Apremilast Tablets, 10 mg, 20 mg, and 30 mg. The medicine is indicated for the treatment of adult patients with active psoriatic arthritis. Psoriatic arthritis is a long-term inflammatory arthritis. It occurs in individuals […] More

  • in Health care

    Conduct PK study for repeated dose and Phase III CT : CDSCO Panel tells Sun Pharma on Psoriatic drug combination

    by

    New Delhi: Rejecting the drug major Sun Pharma’s proposal for a Phase III clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined that the firm should conduct the pharmacokinetic (PK) study for repeated dose and the Phase III clinical trial of the fixed-dose combination […] More